Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Transplant Recipients
100%
Hepatitis C Virus
100%
Chronic Hepatitis C
100%
Hepatitis C Virus RNA
28%
HIV Patients
28%
Highly Active Antiretroviral Therapy (HAART)
28%
MELD Score
28%
Liver Transplantation
14%
African American
14%
Risk Factors
14%
Interferon-α (IFN-α)
14%
Associated Complications
14%
Intolerance
14%
Patient Survival
14%
Ribavirin
14%
Pretransplant
14%
Poor Survival
14%
HIV Infection
14%
Poor Outcome
14%
Cirrhosis
14%
HIV-positive
14%
HIV-negative
14%
Aging Model
14%
Hepatitis C
14%
Graft Loss
14%
Sustained Virological Response
14%
Patient Matched
14%
Patient Mortality
14%
Co-infected Patients
14%
Medicine and Dentistry
Liver Graft
100%
Hepatitis C Virus
100%
Human Immunodeficiency Virus
100%
Hepatitis C
100%
Virus RNA
22%
Highly Active Antiretroviral Therapy
22%
Model For End Stage Liver Disease Score
22%
Liver Transplantation
11%
Interferon
11%
Transplantation
11%
Liver Cirrhosis
11%
Human Immunodeficiency Virus Infection
11%
Graft Failure
11%
Ribavirin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
100%
HIV
100%
Hepatitis C
100%
End Stage Liver Disease
22%
Virus RNA
22%
Interferon
11%
Ribavirin
11%
Liver Cirrhosis
11%
Human Immunodeficiency Virus Infection
11%
Graft Failure
11%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Hepatitis C Virus
100%
Hepatitis C
100%
RNA Virus
22%
Liver Transplantation
11%
interferon
11%
Human Immunodeficiency Virus Infection
11%
Ribavirin
11%
Nursing and Health Professions
Model For End Stage Liver Disease Score
18%
Ribavirin
9%
Cholestatic Hepatitis
9%